batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Kelun hits dato-dxd while it's down 28 November 2024 Cabometyx’s Cabinet committee 27 November 2024 Merck gets high with subcutaneous Keytruda 27 November 2024 EU backs Tevimbra's stomach restriction – and then some 27 November 2024 Roche’s Skyscraper crumbles 26 November 2024 ASH 2024 preview – Incyte gets a Monjuvi coup 25 November 2024 Halozyme abandons Evotec proposal 25 November 2024 Perspective's lead balloon 21 November 2024 Load More